LIGAND PHARMACEUTICALS INC Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Ligand Pharmaceuticals Inc Interest Expense for the quarter ending March 31, 2024 was $141K, a 41.3% decline year-over-year.
  • Ligand Pharmaceuticals Inc Interest Expense for the twelve months ending March 31, 2024 was $557K, a 55.4% decline year-over-year.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2023 was $656K, a 63.5% decline from 2022.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2022 was $1.8M, a 90.8% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2021 was $19.6M, a 28.4% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $656K -$1.14M -63.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $1.8M -$17.8M -90.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $19.6M -$7.8M -28.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $27.4M -$8.33M -23.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $35.7M -$12.5M -26% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $48.3M +$34.8M +259% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $13.5M +$618K +4.81% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $12.8M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2014 $4.86M +$2.78M +134% Jan 1, 2014 Dec 31, 2014 10-K 2015-02-23
2013 $2.08M -$847K -29% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-23
2012 $2.92M +$416K +16.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 $2.51M +$2.45M +4224% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-14
2010 $58K Jan 1, 2010 Dec 31, 2010 10-K/A 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.